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Abstract: Claudin-2 is highly expressed in human lung adenocarcinoma tissues and may be a
novel target for cancer chemotherapy because knockdown of claudin-2 decreases cell proliferation.
We found that flavonoids including kaempferol, chrysin, and luteolin concentration-dependently
decrease claudin-2 expression in lung adenocarcinoma A549 cells. Claudin-2 expression is
up-regulated by mitogen-activated protein kinase kinase (MEK)/ extracellular signal-regulated kinase
(ERK)/c-Fos and phosphoinositide 3-kinase (PI3K)/Akt/nuclear factor-κB (NF-κB) pathways, but
these activities were not inhibited by kaempferol, chrysin, and luteolin. Promoter deletion assay using
luciferase reporter vector showed that kaempferol and luteolin inhibit the function of transcriptional
factor that binds to the region between −395 and −144 of claudin-2 promoter. The decrease in
promoter activity was suppressed by mutation in signal transducers and activators of transcription
(STAT)-binding site, which is located between −395 and −144. The phosphorylation level of STAT3
was not decreased, but the binding of STAT3 on the promoter region is suppressed by kaempferol
and luteolin in chromatin immunoprecipitation assay. The inhibition of cell proliferation caused by
kaempferol and luteolin was partially recovered by ectopic claudin-2 expression. Taken together,
kaempferol and luteolin decreased claudin-2 expression and proliferation in A549 cells mediated
by the inhibition of binding of STAT3 on the promoter region of claudin-2. The intake of foods and
nutrients rich in these flavonoids may prevent lung adenocarcinoma development.
Keywords: lung adenocarcinoma; claudin-2; kaempferol; chrysin; STAT3
1. Introduction
Epithelial cells form tight junctions (TJs) at the most apical pole of the lateral membrane between
neighboring cells. The TJs regulate the flux of ions and solutes through the paracellular pathway, cell
proliferation, polarization, and differentiation [1–3]. Most solid cancers are derived from epithelial
tissues and disruption of polarity accelerates cell proliferation and differentiation. Claudins are integral
membrane proteins of TJs and comprise a large family of 27 subtypes in a mammal [4,5]. Dysregulation
of claudins expression has been shown in various tumor tissues [6]. We have been reported that the
expression of claudin-2 is up-regulated in human lung adenocarcinoma tissues [7]. Similarly, the
elevation of claudin-2 expression is reported in liver [8], colon [9], and stomach cancer tissues [10].
The knockdown of claudin-2 decreases proliferation and migration in non-small-cell lung carcinoma
cells [7,11]. Therefore, claudin-2 may be one of the targets for anticancer function of foods and drugs.
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Anticancer activity is reported in polyphenols extracted from plants, fruits, vegetables, and bee
propolis [12,13]. Polyphenols include many classes of compounds ranging from flavonoids, phenolic
acids, and anthocyanins. Some flavonoids inhibit growth and invasion of cancer cells in various
in vitro and in vivo models. A population-based case-control study in Montreal, Canada, reported
that a low dietary intake of flavonoids increases the risk of lung cancer [14]. Antioxidant effect is
one of the key factors to reduce cancer risk [15]. Flavonoids have a basic structure consisting of
two aromatic rings linked by three carbon atoms that are confined in an oxygenated heterocycle
ring, and clarified as flavonols, flavones, flavanones, flavanols, anthocyanidins, and isoflavones [16].
The antioxidant activity is affected by the number and position of hydroxyl substituents [17]. Quercetin,
with 3′,4′ dihydroxy substituents in the B ring and conjugation between the A and B rings has strong
antioxidant activity, and shows apoptotic and anti-proliferative effects in human cancer cells derived
from lung [18], breast [19], gastrointestinal tract [20], and prostate [21]. We previously reported that
quercetin decreases claudin-2 expression in human lung adenocarcinoma A549 cells [22]. However,
other flavonoids that decrease claudin-2 expression have not been identified.
The expression of claudins is controlled by various transcriptional factors under physiological
and pathophysiological conditions. Signal transducers and activators of transcription (STAT) forms
a family with seven members in mammals (STAT1, STAT2, STAT3, STAT4, STAT5A, STAT5B, and
STAT6) [23]. Among them, STAT3 and STAT5 are activated in a large number of human cancers
and play major roles in proliferation, apoptosis, and angiogenesis [24]. The activation of tyrosine
kinase signal promotes dimerization of STAT3 and its translocation into the nuclei. STAT3 binds to the
promoter regions of tumor-related genes [25]. A few reports indicate that STATs are involved in the
regulation of claudins expression. The activation of STAT1 and STAT3 decreases claudin-5 expression
in human brain microvascular endothelial cells [26] and claudin-2 expression in Madin-Darby canine
kidney (MDCK) II cells [27], respectively, but the binding site of STAT on the promoter region of
claudins is unknown.
In the present study, we searched for new substances that can decrease claudin-2 expression in
A549 cells and identified kaempferol, chrysin, and luteolin as the potential candidates. To clarify the
mechanism, we examined the effects of these flavonoids on intracellular signaling factors, promoter
activity of claudin-2, binding of transcriptional factor on promoter of claudin-2, and cell proliferation.
Our results indicate that kaempferol and luteolin may decrease claudin-2 expression through inhibiting
the interaction of STAT3 on promoter region of claudin-2 without affecting the phosphorylation of
STAT3, resulting in suppression of cell proliferation.
2. Experimental Section
2.1. Materials
Rabbit anti-claudin-1 and mouse anti-claudin-2 antibodies were obtained from Thermo Fisher
Scientific (Waltham, MA, USA). Goat anti-β-actin and rabbit anti-phosphorylated-c-Fos (p-c-Fos)
antibodies were from Santa Cruz Biotechnology (Santa Cruz, CA, USA). Rabbit anti-p-Akt, rabbit
anti-Akt, rabbit anti-ERK1/2, rabbit anti-c-Fos, rabbit anti-p-NF-κB p65 (Ser536), and rabbit anti-NF-κB
p65 antibodies were from Cell Signaling Technology (Beverly, MA, USA). Mouse anti-p-STAT3,
anti-STAT3, and anti-nucleoporin p62 antibodies were from BD Biosciences (San Jose, CA, USA).
Apigenin, genistein, and quercetin were from Wako Pure Chemical Industries (Osaka, Japan). Chrysin,
kaempferol, daidzein, and 7-hydroxyflavone were from Tokyo Kasei Kogyo (Tokyo, Japan). Hesperetin
was from LKT Laboratories (St. Paul, MN, USA). Luteolin and 4′-hydroxyflavone were from
INDOFINE Chemical Company (Hillsborough, NJ, USA). Flavonoids were dissolved in dimethyl
sulfoxide (DMSO). All other reagents were of the highest grade of purity available.
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2.2. Cell Culture and Transfection
The human lung adenocarcinoma A549 cell line was obtained from the RIKEN BRC through
the National Bio-Resource Project of the MEXT, Japan. The cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM, Sigma-Aldrich, St. Louis, MO, USA) supplemented with 5% fetal calf
serum (FCS, HyClone, Logan, UT, USA), 0.07 mg/mL penicillin-G potassium, and 0.14 mg/mL
streptomycin sulfate in a 5% CO2 atmosphere at 37 ◦C. The experiments were done in subconfluent
culture condition (about 70–80% confluent), because the expression of claudin-2 decreased in 100%
confluent condition [11]. The cells were treated with vehicle DMSO (control) and flavonoids (1–50 µM)
for 24 h in FCS-free DMEM. The vector containing human claudin-2 cDNA was prepared as described
previously [11]. The FLAG-tagged claudin-2 was sub-cloned into pTRE2-hyg vector and transfected
into A549 cells with Lipofectamine 2000 as recommended by the manufacturer. Stable transfectants
were selected with 500 ng/mL hygromycin B and maintained in the continuous presence of 50 ng/mL
hygromycin B.
2.3. SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Immunoblotting
Cells were scraped into cold phosphate-buffered saline and precipitated by centrifugation.
They were lysed in a radioimmunoprecipitation assay lysis buffer containing 150 mM NaCl, 0.5 mM
ethylenediaminetetraacetic acid, 1% Triton X-100, 0.1% sodium dodecyl sulfate, 50 mM Tris-HCl
(pH 8.0), a protease inhibitor cocktail (Sigma-Aldrich), and sonicated for 20 s. The aliquots were used
as whole cell extracts. After centrifugation at 6000× g for 5 min, the supernatants were collected and
used as cell lysates which including plasma membrane and cytoplasmic proteins. Nuclear fractions
were prepared using NE-PER nuclear and cytoplasmic fraction reagents as recommended by the
manufacturer (Thermo Fisher Scientific). Samples were applied to SDS-PAGE and blotted onto
a polyvinylidene difluoride membrane. The membrane was then incubated with each primary
antibody (1:1000 dilution) at 4 ◦C for 16 h, followed by a peroxidase-conjugated secondary antibody
(1:5000 dilution) at room temperature for 1 h. Finally, the blots were incubated in Pierce Western
Blotting Substrate (Thermo Fisher Scientific) and exposed to film, or incubated in ECL Prime Western
Blotting Detection System (GE healthcare, Chalfont St Giles, UK) and scanned with a C-DiGit Blot
Scanner (LI-COR Biotechnology, Lincoln, NE, USA). Blots were further stripped and reprobed with
anti-β-actin antibody. Band density was quantified with ImageJ software (National Institute of Health
software, NIH, Bethesda, MD, USA). The signals were normalized for the loading control β-actin
or nucleoporin p62. The expression levels were represented relative to the values in the absence
of flavonoids.
2.4. Measurement of O2− Scavenging Activity
Antioxidant activity of flavonoids and antioxidants was measured using the
hypoxanthine-xanthine oxidase system as the source of superoxide anion [28]. Reaction solution
contains 10 µM 2-methyl-6-p-methoxyphenyl ethynylimidazopyrazynone, 0.02 units/mL xanthine
oxidase, 0.12 mM hypoxanthine, and 20 mM KH2PO4 (pH 7.5). Test compounds were mixed in the
reaction buffer at the final concentration of 50 µM. A chemiluminescence intensity was measured with
a luminometer (AB-2270 Luminescencer Octa, ATTO, Tokyo, Japan). O2− scavenging activity was
calculated by the following formula: Scavenging activity (%) = (1 − CLS/CLC) × 100; where CLC,
chemiluminescence of control, CLA, chemiluminescence of sample.
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2.5. RNA Isolation and Polymerase Chain Reaction (PCR)
Total RNA was isolated from A549 cells using TRI reagent (Sigma-Aldrich). Reverse transcription
was carried out with ReverTra Ace qPCR RT Kit (Toyobo Life Science, Osaka, Japan). Semi-quantitative
PCR was carried out with DNA Engine Dyad Cycler (Bio-Rad, Richmond, CA, USA) using GoTaq
DNA polymerase (Promega, Madison, WI, USA). The PCR product was visualized with ethidium
bromide after electrophoretic separation on a 2% agarose gel. The size of PCR product was 86 bp
(claudin-2) and 100 bp (β-actin). Quantitative real-time PCR was performed with a Thermal Cycler
Dice Real-time System (TP700, Takara Bio, Shiga, Japan) or Eco Real-Time PCR system (AS One, Osaka,
Japan) using KOD SYBR qPCR Mix (Toyobo Life Science). The primers used to PCR are listed in
Table 1. The threshold cycle (Ct) for each PCR product was calculated with the instrument’s software,
and Ct values obtained for claudin-1 and -2 were normalized by subtracting the Ct values obtained for
β-actin. The resulting ∆Ct values were then used to calculate the relative change in mRNA expression
as a ratio (R) according to the equation R = 2−(∆Ct(treatment)−∆Ct(control)).












2.6. Luciferase Reporter Assay
Using the reporter plasmids containing fragments of −1031/+37, −393/+37, −143/+37,
and −87/+37 of human claudin-2, luciferase reporter assay was carried out as described
previously [29]. The mutant of putative STAT-binding site (−252/−230) was generated using
the primer pairs (forward: 5′-GAATCTCGAGCAGCCACCTGTCTGGCTCCTGGC-3′ and reverse:
5′-AGGTGATGATGGCAGTGGTGGTTGTG-3′) and KOD-Plus-mutagenesis kit (Toyobo Life Science).
The luminescence of luciferase was measured with a luminometer.
2.7. Chromatin Immunoprecipitation (ChIP) Assay
Cells were treated with 1% formaldehyde to crosslink the protein to the DNA. ChIP assay
was carried out as described previously [29]. To co-immunoprecipitate the DNA, anti-STAT3
antibody or mouse IgG was used. The eluted DNA was amplified by quantitative PCR using
the primer pairs for claudin-2 promoter (forward: 5′-ACTTGAGTTAACACAGCCACCA-3′ and
reverse: 5′-ACTTTGAACGTGGAGCCAAAAT-3′). To confirm the same amounts of chromatins used
in immunoprecipitation between groups, input chromatin was also used.
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2.8. Cell Proliferation
Cells were seeded at 1 × 105 cells in 60-mm dishes. After 24, 48, and 72 h of culture, the cell
images were captured with a light microscope (CKX53, Olympus, Tokyo, Japan). Cell proliferation
was calculated by counting the number of cells using the CKX-CCSW software (Olympus).
2.9. Statistics
Results are presented as means ± S.E.M. Differences between groups were analyzed with a
one-way analysis of variance, and corrections for multiple comparison were made using Tukey’s
multiple comparison test. Comparisons between two groups were made using Student’s t-test. Statics
were performed using KaleidaGraph version 4.5.1 software (Synergy Software, Reading, PA, USA).
Significant differences were assumed at p < 0.05.
3. Results
3.1. Effects of Flavonoids on Claudin-2 Expression in A549 Cells
The protein level of claudin-2 in the cytoplasmic fraction was significantly decreased by quercetin,
apigenin, kaempferol, chrysin, luteolin, and daizein at the concentration of 50 µM in A549 cells
(Figure 1). The effects of kaempferol, chrysin, and luteolin were stronger than those of other flavonoids.
Genistein and hesperetin showed no effect on claudin-2 expression. Hesperetin, kaempferol, and
luteolin showed cytotoxicity at over 100 µM, but all flavonoids have little effect on cytotoxicity at the
concentration of lower than 50 µM (Supplementary Figure S1). These results indicate that the decrease
in claudin-2 expression is not due to cytotoxicity. The expression of other junctional proteins including
claudin-1, occludin, and E-cadherin was not changed by these flavonoids. In the present study, we
focused on the regulatory mechanism of which kaempferol, chrysin, and luteolin decrease claudin-2
expression because the effects of these flavonoids are the strongest.
3.2. Effects of Antioxidant Capacity on Claudin-2 Expression
The expression of claudin-2 was dose-dependently decreased by kaempferol, chrysin, and luteolin
(Figure 2). The effects were significant over the concentration of 1 or 10 µM. Certain flavonoids have
an antioxidant effect. Kaempferol, chrysin, and luteolin showed approximately 20% O2− scavenging
activity at 50 µM (Figure 3). 4′-Hydroxyflavonoe and 7-hydroxyflavone had little antioxidant activity,
which is similar to previous report [30]. In contrast, N-acetyl cysteine (NAC, 1 mM) and reduced
glutathione (GSH, 0.1 mM) had strong antioxidant activity. Although 4′-hydroxyflavonoe and
7-hydroxyflavone had little antioxidant activity, they decreased claudin-2 expression (Figure 4).
In addition, claudin-2 expression was not decreased by NAC and GSH. These results indicate that
antioxidant capacity may not be involved in the decrease in claudin-2 expression by flavonoids.
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Figure 1. Effects of flavonoids on expression of junctional proteins in A549 cells. Cells were 
incubated in the absence and presence of 50 μM flavonoids including quercetin, apigenin, genistein, 
hesperetin, kaempferol, chrysin, luteolin, and daidzein for 24 h. Cell lysates were immunoblotted 
with anti-claudin-2, anti-claudin-1, anti-occludin, anti-E-cadherin, or anti-β-actin antibody. The 
expression levels were represented relative to the values in control. n = 3–4. ** p < 0.01 significantly 
different from control. NS, not significantly different. 
Figure 1. Effects of flavonoids on expression of junctional proteins in A549 cells. Cells were
incubated in the absence and presence of 50 µM flavonoids including quercetin, apigenin, genistein,
hesperetin, kaempferol, chrysin, luteolin, and daidzein for 24 h. Cell lysates were immunoblotted with
anti-claudin-2, anti-claudin-1, anti-occludin, anti-E-cadherin, r anti-β-actin antibody. The expression
levels w represented relative o the values in control. n = 3–4. ** p < 0.01 significantly different from
control. NS, not significantly different.
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Figure 2. Dose-dependent effects of kaempferol, chrysin, and luteolin on claudin-2 expression. The 
cells were incubated in the absence and presence of kaempferol (A), chrysin (B), or luteolin (C) for 24 
h at the concentration indicated. Cell lysates were immunoblotted with anti-claudin-2 or β-actin 
antibody. The expression levels of claudin-2 were represented relative to the values in 0 μM. n = 3–4. 
** p < 0.01 significantly different from 0 μM. NS, not significantly different. 
 
Figure 3. Antioxidant effects of flavonoids and antioxidants. O2− scavenging activity was examined 
using the hypoxanthine-xanthine oxidase system. Flavonoids (50 μM), N-acetyl cysteine (NAC, 1 
mM), and reduced glutathione (GSH, 0.1 mM) were mixed in the reaction buffer. n = 4. 
Figure 2. Dose-dependent effects of kaempferol, chrysin, and luteolin on claudin-2 expression. The cells
were incubated in the absence and presence of kaempferol (A), chrysin (B), or luteolin (C) for 24 h at
the concentration indicated. Cell lysates were immunoblotted with anti-claudin-2 or β-actin antibody.
The expression levels of claudin-2 were represented relative to the values in 0 µM. n = 3–4. ** p < 0.01
significantly different from 0 µM. NS, not significantly different.
Nutrients 2017, 9, 597 7 of 17 
 
 
Figure 2. Dose-dependent effects of kaempferol, chrysin, and luteolin on claudin-2 expression. The 
cells were incubated in the absence and presence of kaempferol (A), chrysin (B), or luteolin (C) for 24 
h at the concentration indicated. Cell lysates were immunoblotted with anti-claudin-2 or β-actin 
antibody. The expression levels of claudin-2 were represented relative to the values in 0 μM. n = 3–4. 
** p < 0.01 significantly different from 0 μM. NS, not significantly different. 
 
Figure 3. Antioxidant effects of flavonoids and antioxidants. O2− scavenging activity was examined 
using the hypoxanthine-xanthine oxidase system. Flavonoids (50 μM), N-acetyl cysteine (NAC, 1 
mM), and reduced glutathione (GSH, 0.1 mM) were mixed in the reaction buffer. n = 4. 
Figure 3. Antioxidant effects of flavonoids and antioxidants. O2− scavenging activity was examined
using the hypoxanthine-xanthine oxidase system. Flavonoids (50 µM), N-acetyl cysteine (NAC, 1 mM),
and reduced glutathione (GSH, 0.1 mM) were mixed in the reaction buffer. n = 4.
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Figure 4. Effects of non-antioxidative flavones and antioxidants on claudin-2 expression. (A,B) The 
cells were incubated in the absence and presence of 4′-hydroxyflavone or 7-hydroxyflavone for 24 h 
at the concentration indicated. Cell lysates were immunoblotted with anti-claudin-1, claudin-2, or 
β-actin antibody. The expression levels of claudin-1 and -2 were represented relative to the values in 
0 Μm; (C) Cells were incubated in the absence (control) and presence of NAC (1 mM) or GSH (0.1 
mM) for 24 h. Cell lysates were immunoblotted with anti-claudin-1, claudin-2, or β-actin antibody. 
The expression levels of claudin-1 and -2 were represented relative to the values in control. n = 3. ** p 
< 0.01 significantly different from 0 μM or control. NS, not significantly different. 
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claudin-2 is up-regulated by the MEK/ERK/c-Fos [29] and PI3K/Akt/NF-κB pathways [31]. Some 
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for 24 h at the co centration indicated. Cell lysates were immunoblotted with anti-claudin-1, claudin-2,
or β-actin antibody. The expression levels of claudin-1 and -2 were represented relative to the values
in 0 Mm; (C) Cells were incubated in the absence (control) and presence of NAC (1 mM) or GSH
(0.1 mM) for 24 h. Cell lysates were immunoblotted with anti-claudin-1, claudin-2, or β-actin antibody.
The expression levels of claudin-1 and -2 were represented relative to the values in control. n = 3.
** p < 0.01 significantly different from 0 µM or control. NS, not significantly different.
3.3. Effects of Flavonoids on mRNA Levels of Junctional Protein and Intracellular Signaling Pathway
Kaempferol, chrysin, and luteolin significantly de reased the mRNA level of claudin-2 without
changing that of claudin-1 (Figure 5). These results coincide with those of Western blotting. In contrast,
the mRNA level of occludin was increased by kaempferol and those of occludin and E-cadherin
were decreased by luteolin. We previously reported that the transcriptional activity of claudin-2 is
up-regulated by the MEK/ERK/c-Fos [29] and PI3K/Akt/NF-κB pathways [31]. Some flavonoids,
including kaempferol, chrysin, and luteolin, increased the phosphorylation levels of ERK1/2 and/or
c-Fos (Figure 6). On the contrary, these flavonoids had no effect on the phosphorylation of Akt and
NF-κB 65. These results indicate that the MEK/ERK/c-Fos and PI3K/Akt/NF-κB pathways may not
be involved in these flavonoids-induced decreases in claudin-2 expression.
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3.4. Effects of Flavonoids on the Promoter Activity of Claudin-2
To clarify a major transcriptional factor involved in the flavonoids-induced decreases in claudin-2
expression, we performed the promoter deletion assay of human claudin-2. Apigenin, kaempferol,
chrysin, and luteolin significantly decreased the promoter activity (Figure 7). These results coincide
with those of Western blotting. In contrast, quercetin, genistein, hesperetin, and daidzein did not
inhibit the promoter activity. Kae pferol, chrysin, and luteolin inhibited the activity of construct
of −395/+37, but the inhibitory effects of kaempferol and luteolin disappeared in the constructs of
−143/+37 and −87/+37. In contrast, the promoter activity of all deletion constructs was significantly
inhibited by chrysin. These results indicate that the kaempferol- and luteolin-sensitive transcriptional
factor may bind to the region between −395 and −144, and chrysin-sensitive one may bind to the
region between −86 and −1. TFSEARCH showed that the region between −395 and −144 of claudin-2
promoter contains a putative STAT-binding site. The promoter activity of mutant of STAT-biding site
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was not significantly inhibited by kaempferol and luteolin. These results indicate that STAT may be
involved in the decrease in claudin-2 expression by kaempferol and luteolin.
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Figure 7. Effects of flavonoids on the promoter activity of hu an claudin-2. (A) Schematic drawing
of human claudin-2 luciferase reporter vector; (B) The cells were co-transfected with luciferase
−1031/pGL4.10 and pRL-TK vectors. After 24 h of transfection, the cells were incubated in the absence
and presence of 50 µM flavonoids for 24 h. The promoter activity of claudin-2 was represented relative
to the values in control; (C) The constructs of 5′-deletion series including −395, −143, and −87/pGL4
vector were co-transfected with the pRL-TK vector; (D) The construct of mutant of STAT-binding site
was co-transfected with the pRL-TK vector. The relative promoter activity was represented relative to
the values of control of −1031/pGL4 vector. n = 3–4. ** p < 0.01 significantly different from vehicle.
NS, not significantly different.
3.5. Inhibition of Association between STAT3 and Claudin-2 Promoter by Flavonoids
STAT3 is abundantly expressed in lung cancer cells and involved in the development of cancer [32].
The phosphorylation and nuclear localization of STAT3 were not inhibited by kaempferol, chrysin,
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and luteolin (Figure 8). In the ChIP assay, a primer pairs amplifying the STAT-binding site showed
positive PCR signals in the control cells using anti-STAT3 antibody (Figure 8B). In the kaempferol,
chrysin, and luteolin-treated cells, PCR signal was faint. The primer pairs amplifying STAT-binding
site showed PCR bands using input samples. These results indicate that these flavonoids inhibit
interaction between STAT3 and claudin-2 promoter. The interaction between transcriptional factor
and promoter region is often regulated by epigenetic modification, such as histone acetylation [33].
However, three flavonoids did not change acetylation levels of histone H3 (Figure 8C), indicating
that epigenetic mechanism may not be involved in the inhibition of association between STAT3 and
claudin-2 promoter.
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control; (B) After immunoprecipitation of genomic DNA by anti-STAT3 antibody, semi-quantitative 
PCR (left images) and quantitative real-time PCR (right graphs) were performed using the primers 
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Figure 8. Effects of flavonoids on the binding of STAT3 to promoter region of claudin-2. The cells
were incubated in the absence (control) and presence of 50 µM flavonoids for 1 h. (A) Whole cell
extracts and nuclear fractions were immunoblotted with anti-p-STAT3, anti-STAT3, or anti-nucleoporin
p62 antibody. The levels of p-STAT3 were represented relative to the values in control; (B) After
immunoprecipitation of genomic DNA by anti-STAT3 antibody, semi-quantitative PCR (left images)
and quantitative real-time PCR (right graphs) were performed using the primers amplifying the
putative STAT-binding site of claudin-2 promoter. Mouse IgG was used for negative control. Input
chromatin was used for normalization. The amount of PCR products is represented relative to the value
of control cells; (C) Nuclear fractions were immunoblotted with anti-acetyl histone H3 (K14 or K56) or
anti-histone H3 antibody. The levels of acetyl histone H3 were represented relative to the values in
control. n = 3. ** p < 0.01 significantly different from control. NS, not significantly different.
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3.6. Effects of Three Flavonoids and Ectopic Claudin-2 Expression on Cell Proliferation
Claudin-2 is partially involved in the regulation of proliferation in A549 cells [7,11]. Kaempferol,
chrysin, and luteolin decreased claudin-2 expression, so we examined the effects of these flavonoids on
cell proliferation. To avoid the effect of cytotoxicity, the cells were treated with these flavonoids at the
concentration of 10 µM (Supplementary Figure S1). Cell number was not changed by overexpression
of claudin-2 in the absence of flavonoids (Figure 9). Three flavonoids inhibited the increase in cell
number and decreased the expression of claudin-2, which were rescued by ectopic claudin-2 expression.
Therefore, these results indicate that kaempferol, chrysin, and luteolin may inhibit cell proliferation
mediated by the decrease in claudin-2 expression.
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Figure 9. Rescue of cell proliferation by ectopic claudin-2 expression. Mock and claudin-2-overexpressing
cells were cultured in the absence (A) and presence of 10 µM kaempferol (B); chrysin (C); or luteolin (D).
Cell number was measured at 24, 48, and 72 h after inoculation; (E) Cell lysates were immunoblotted with
anti-claudin-2 or β-actin antibody. n = 3–4. ** p < 0.01 and * p < 0.05 significantly different from mock. NS,
not significantly differ nt.
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4. Discussion
The effects of flavonoids on the barrier function and expression of claudins have been examined
in epithelial cells. Quercetin enhances intestinal barrier in Caco-2 cells through the elevation
of claudin-4 [34] and through the assembly of zonula occludens-2, occludin, and claudin-1 [35].
Genistein and daidzein protect lipopolysaccharide-induced disruption of barrier function in glandular
endometrial epithelial cells through the elevation of claudin-3, -4, and -8 [36]. In contrast, the
effects of flavonoids on the pathophysiological function and expression of claudins in cancer cells
have not been examined well. Here, we found that kaempferol, chrysin, and luteolin decrease
the mRNA and protein levels of claudin-2 in lung adenocarcinoma A549 cells. The expression of
claudin-2 is decreased by chemical inhibitors and dominant negative plasmids of MEK/ERK/c-Fos
and PI3K/Akt/NF-κB pathways in A549 cells [7,31]. These factors of intracellular signaling pathway
are activated in the lung cancer tissues [37,38]. However, kaempferol, chrysin, and luteolin did not
inhibit the phosphorylation of ERK1/2 and Akt, but they surprisingly increased these phosphorylation.
We suggest that kaempferol, chrysin, and luteolin decrease claudin-2 expression mediated by the
different mechanisms from MEK/ERK/c-Fos and PI3K/Akt/NF-κB pathways.
The regulatory mechanism of claudin-2 expression is different in each tissue. Claudin-2 expression
is down-regulated by the activation of MEK/ERK pathway in renal tubular Madin Darby canine kidney
type II (MDCK II) cells [39]. The effect of MEK/ERK pathway in MDCK II cells is opposite to that
in A549 cells [29]. At present, it is unknown why the MEK/ERK pathway has contrary effects on
claudin-2 expression in both cells. In intestinal Caco-2 cells, claudin-2 is up-regulated by caudal-related
homeobox 2 (cdx2) [40]. Cdx2 is an intestine-specific transcription factor highly expressed in the tissues
of dysplasia and cancer, but is not expressed in the lung. Therefore, cdx2 should not be involved in
the up-regulation of claudin-2 in lung cancer. To identify novel compounds that decrease claudin-2
expression, we had to search for them based on the novel mechanism of action.
It has been postulated that oxidative stress is closely associated with tumor formation, progression
and metastasis. Numerous naturally occurring anti-oxidant compounds possess anti-cancer
properties [12]. Oxidative stresses including hydrogen peroxide and nitric oxide decrease claudin-1
and -5 expression in colonic HT-29 cells [41], claudin-2 expression in MDCK II cells [42], and claudin-5
expression in ischemic brain [43], which are inhibited by antioxidants. Oxidative stress may be
one of the key factors controlling claudins expression. Kaempferol, chrysin, and luteolin showed
little antioxidative effect at the concentration used in the present study (Figure 3), whereas NAC
and GSH had strong antioxidant activity. Nevertheless, both NAC and GSH did not decrease
claudin-2 expression, whereas 4′-hydroxyflavonoe and 7-hydroxyflavone dose-dependently decreased.
These results suggest that anti-oxidative capacity is not necessary to decrease claudin-2 expression in
A549 cells, but the basic structure of flavones or flavonols is necessary.
Kaempferol, chrysin, and luteolin have been reported to inhibit properties of cancer mediated by
inhibition of phosphorylation of STAT3: Kaempferol induces differentiation in partially differentiated
colon cancer cells [44], chrysin suppresses hypoxia-induced metastasis of 4T1 mouse breast cancer
cells [45], and luteolin inhibits hypoxia-induced vascular endothelial factor expression [46]. In contrast,
our results indicated that these flavonoids do not inhibit the phosphorylation of STAT3, but they block
the interaction between STAT3 and the promoter region of claudin-2. The direct inhibition of the binding
of transcriptional factor and DNA are reported by some flavonoids. Apigenin, chrysin, and kaempferol
bind to peroxisome proliferator-activated receptor γ and suppress inducible cyclooxygenase (COX) and
nitric oxide synthase promoter activity in mouse macrophages [47]. Chrysin binds to nuclear factor for
IL-6 and suppresses COX-2 expression in lipopolysaccharide-activated Raw 264.7 cells [48]. The binding
site of flavonoids on STAT3 is unknown, but kaempferol, chrysin, and luteolin could interfere the
interaction between STAT3 and promoter region of claudin-2.
The pharmacological inhibitor and dominant-negative isoform of STAT3 have been reported
to induce cell cycle arrest in A549 cells [32]. So far, we reported that knockdown of claudin-2
inhibits cell cycle G1/S transition without affecting cytotoxicity [11]. In the present study, kaempferol,
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chrysin, and luteolin showed little cytotoxicity (Supplementary Figure S1) and decreased cell number.
The flavonoids-induced decrease in cell number was significantly rescued by ectopic claudin-2
expression. Therefore, we suggest that these flavonoids inhibit cell proliferation mediated by the
reduction of claudin-2 expression.
5. Conclusions
In the present study, we found that kaempferol, chrysin, and luteolin decrease claudin-2 expression
in A549 cells. Kaempferol and luteolin inhibited the promoter activity of human claudin-2, which was
rescued by deletion or mutation of STAT-binding site. The phosphorylation and nuclear localization
of STAT3 were not inhibited by kaempferol and luteolin, but the interaction between STAT3 and the
promoter region of claudin-2 was inhibited, indicating that kaempferol and luteolin may directly block
the interaction of STAT3 on DNA. Chrysin also inhibited the promoter activity of claudin-2, which was
not rescued by deletion of STAT-binding site. Other important transcriptional factors, which bind to
the region between −86 and −1 of claudin-2 promoter, should be involved in the inhibitory effect of
chrysin. Some foods that abundantly include these flavonoids may be useful to prevent development
of lung adenocarcinoma.
Supplementary Materials: The following are available online at www.mdpi.com/2072-6643/9/6/597/s1,
Figure S1: Effects of flavonoids on cell viability.
Acknowledgments: This work was supported in part by grants from the Takeda Science Foundation, the Futaba
Electronics Memorial Foundation, and the Takahashi Sangyo-Keizai Research Foundation, and collaborative
research grant from API Co., Ltd. (Gifu, Japan).
Author Contributions: H.S. and A.T. performed experiments and analyzed the data. S.E., T.M., T.F. and K.I.
contributed the experiment plan and discussion of the manuscript. A.I. contributed to supervision of the project,
interpretation of the data and writing the paper.
Conflicts of Interest: The authors declare no conflict of interest.
Abbreviations
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